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The complete
nucleotide
sequences
of the hemagglutinin/esterase
(HE) genes of human coronavirus
(HCV) strain
OC43 and bovine respiratory
coronavirus
(BRCV) strain G95 were determined
from single-stranded
cDNA fragments
generated
by reverse
transcription
of virus-specific
mRNAs
and amplified
by polymerase
chain reaction.
An open
reading frame of 1272 nucleotides
was identified
as the putative
HE gene by homology
to the bovine coronavirus
HE
gene. This open reading frame encodes
a protein of 424 amino acids with an estimated
molecular
weight of 47.7 kDa.
Ten potential
N-linked
glycosylation
sites were predicted
in the HE protein
of HCV-OC43
while nine of them were
present in BRCV-GS5.
Fourteen
cysteine
residues were conserved
in the HE proteins
of both viruses.
Two hydrophobic
sequences
at the N-terminus
and the C-terminus
may serve as signal peptide and transmembrane
anchoring
domain,
respectively.
The predicted
HE protein
of HCV-OC43
was 95% identical
to the HEs of BRCWG95
and other bovine
coronaviruses,
and 60% identical
to the HEs of mouse hepatitis
viruses.
Phylogenetic
analysis suggests
that the HE
genes of coronaviruses
and influenza
C virus have a common
ancestral
origin, and that bovine coronaviruses
and
HCV-OC43
are closely
related.
0 1992 Academic
Press, Inc.

binding) and acetylesterase
(receptor-destroying)
activities similar to the HE (or HEF) glycoprotein of influenza
C virus (ICV) (12-20). It was shown that the HE glycoprotein of BCV strain Quebec induces neutralizing antibodies both in vitro and in viva and thus, is important in
viral infectivity (21, 22). It is evidently not required for
viral infectivity in MHV-A59 and MHV-JHM (11). The
role of the HE gene and its protein in coronavirus
evolution, replication, and pathogenesis
remains unclear.
The exact genomic organization of HCV-OC43 is not
known. Antigenic and nucleic acid hybridization studies indicate that the HCV-OC43
is closely related to
BCV (23-25).
By analogy to BCV, the order of the
genes coding for the structural proteins probably is 5’HE-S-M-N-3’.
Recently, the N gene of HCV-OC43 was
sequenced,
and it was found to be similar to BCV N
gene (97.59/o amino acid sequence
homology) (26).
The origin and evolutionary
relationships
among the
HE genes of hemagglutinating
coronaviruses
isolated
from different species are poorly understood. To elucidate the molecular evolution of the coronavirus
HE
genes, we sequenced the HE genes of HCV-OC43,
a
bovine respiratory coronavirus
(BRCV), a virulent, and
an avirulent BCV strains. We report here the complete
nucleotide sequence of the HE genes of HCV-OC43
and BRCV-G95, and their phylogenetic relatedness
to
BCVs, MHV, and ICV.
HCV-OC43
was obtained from the American Type
Culture Collection (ATCC, 759-VR) and propagated in
human rectal tumor (HRT-18) cells as described previ-

Coronaviruses
possess a single-stranded,
nonsegmented RNA genome of positive polarity (1, 2) and are
associated with a variety of diseases in man and animals (3-5). Coronaviruses
are divided into two major
antigenic groups. The first group includes human coronavirus strain OC43 (HCV-OC43),
bovine coronavirus
(BCV), mouse hepatitis virus (MHV), and hemagglutinating encephalomyelitis
virus of swine (HEV) (2, 5).
HCV-OC43 causes respiratory infection of man similar
to those of influenza viruses (6). BCV causes enteritis
of newborn calves and is also considered to be an etiological factor of respiratory
diseases of calves (7, 8).
MHV can infect different organs, causing enteric, respiratory, and neurological diseases (5, 9). A unique property of coronaviruses
within this antigenic cluster is the
presence
of the hemagglutinin/esterase
(HE) gene.
The genome of MHV-A59 contains an open reading
frame (ORF), which may code for an HE protein. However, the HE is not expressed in infected cells (10, 11,
23). The second group, which includes HCV strain
229E, avian infectious bronchitis virus (IBV), porcine
transmissible
gastroenteritis
virus, and feline infectious peritonitis virus, lacks an HE gene (2, 5).
The HE glycoproteins
of HCV-OC43,
BCV, MHVJHM, and HEV possess
hemagglutination
(receptorSequence
data from this article have been deposited
EMBUGenbank
Libraries
under Accession
Nos. M76373
OC43 and M80842
for BRCWG95.
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ously (27). A bovine respiratory
coronavirus
strain
Giessen 89-4595 (G95) was kindly provided by Dr. W.
Herbst, Institute of Hygiene and Infectious Diseases of
Animals, Justus Liebig University Giessen, Germany.
This virus was originally isolated from nasal swabs of a
calf suffering from respiratory
disorder,
and propagated in HRT-18 cells. Isolation and purification of viral
RNA, cDNA synthesis, double-stranded
(ds) cDNA amplification and single-stranded
(ss) cDNA production by
polymerase chain reaction (PCR), as well as DNA sequencing were performed
as described
previously
(28, 44).
Primers were designed to generate cDNA fragments
from virus-specific
mRNAs by reverse transcription
and
PCR amplification, based on the high degree of genomic similarity between HCV-OC43 and BCVs (25, 26).
These primers were previously used for amplification
and sequencing of BCV S and HE genes (28,44). PCRgenerated cDNA fragments were directly sequenced
in both directions. Analysis of the sequences
revealed
that a large ORF of 1272 nucleotides was identical in
size to the HE genes of BCVs (29, 30, 44). This ORF
terminated 14 nucleotides upstream from the S gene
(Zhang eta/., unpublished data), and encoded a protein
of 424 amino acid residues with an estimated molecular weight of 47.7 kDa (Figs. 1 and 2). Two identical
sequences
(CTAAAC), similar to the consensus
intergenie sequence upstream of the HCV-OC43
N gene
(CTAAAT) (26) and identical to the consensus
sequence upstream of BCV HE and S genes, were found
16 nt upstream of the predicted initiation codon (at nucleotides 16 to 18) for the HE protein and 8 nt downstream from the termination codon, respectively.
Hydropathic
analysis of the predicted amino acid sequence
indicated
that the putative
HE protein
possessed
the characteristics
of a membrane protein.
Specifically, a hydrophobic stretch of 15 amino acids at
the N-terminus
may serve as signal peptide with a
cleavage site between amino acids 15 and 16 (30, 31,
44). Another hydrophobic
amino acid sequence near
the C-terminus (amino acids 389 to 414) may serve as
the transmembrane
domain anchoring the protein in
the viral envelope. A hydrophilic sequence of 10 amino
acids at the C-terminus may serve as an intravirion-domain. Ten potential A/-linked glycosylation
sites were
predicted in the HE protein of HCV-OC43 while nine of
them were present in that of BRCV-G95. Two internal
ORFs were predicted within the large ORF extending
from nt 107 to 517 and from 976 to 1228. By analogy to
BCV HE gene, these results suggest that the predicted
large ORF 2b represents
mRNA 2-l of HCV-OC43 and
BRCV-G95, encoding the HE glycoprotein.
The predicted amino acid sequences
of the HE
genes from HCV-OC43 and BRCV-G95 (Fig. l), BCV-
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Mebus (30), BCV-Quebec
(29), BCV-L9, BCV-LY138
(44), MHV-A59 (IO), MHV-JHM (11) were aligned using
the programs of the University of Wisconsin
Genetic
Computer Group software
package, version 6.1. The
alignment revealed that the HE gene of HCV-OC43
was more closely related to BRCV-95 and BCVs than to
MHVs. Nucleotide and amino acid sequences
among
HCV-OC43, BRCV-G95, and BCVs were 95.8 to 96.3%
and 94.1 to 94.8% identical, respectively,
while the
amino acid sequence identity between HCV-OC43 and
MHVs was approximately 60%. Fourteen cysteine residues were strictly conserved
in the HE proteins of
HCV-OC43,
BRCV-G95, BCVs, and MHVs. The MHVJHM had 15 amino acids and two cysteine residues
more than HCV-OC43
and BRCV-G95. The alignment
indicated that the eight HE genes among coronaviruses can be divided into two groups. The first group
includes HCV-OC43, BRCV-G95, and all BCVs, and the
second group includes MHV-JHM and MHV-A59.
To identify a possible evolutionary pathway for the
HE gene of coronaviruses,
we compared the coronavirus HE genes with the ICV HE gene. An alignment of
the predicted amino acid sequences
is shown in Fig. 2.
In this alignment, the ICV HE1 subunit shows a sequence identity of approximate 28.2% with the HE protein of HCV-OC43,
BRCV-G95, and BCVs, and 26.3%
with the HE protein of MHVs. The alignment shows
that several regions are completely identical. Most importantly, the putative acetylesterase
active site (F-GD-S) (at amino acids 72 to 75 in Fig. 2) is conserved in
all HE proteins of human, bovine, and murine coronaviruses and ICV. Ten of the 14 cysteine residue positions of HCV-OC43
are conserved among all HE proteins compared. These data suggest that these proteins may be evolutionarily related to each other.
DNA sequences
for each gene were optimally
aligned based on the alignment of their respective
amino acid sequences
(Fig. 2). A maximum parsimony
analysis was per-formed on the aligned DNA sequences to predict possible phylogenetic relationships
among coronaviruses
(detailed methodology
for the
phylogenetic, computer-assisted
analysis is described
in the legend of Fig. 3). Cladistic analysis of the DNA
sequence data resulted in a single phylogenetic
hypothesis (phylogram) with a total length of 1503 steps
and a resealed consistency
index of 0.962. This analysis suggested
that all coronaviruses
were divided in
two clades. One clade included HCV-OC43,
BRCVG95, and BCVs. The other clade consisted
of MHVJHM and MHV-A59.
Neither coronaviral clade is derived from the other. Within the clades, all BCVs were
closely related taxa to HCV-OC43,
and the MHV-JHM
and MHV-A59 were sister taxa. The phylogram sug-
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FIG. 1. Nucleotide
and deduced
amino
acid sequences
of the HE gene of HCV-OC43
and BRCV-G95.
The primers
3S95
(5’.
ATGGAAACCGTAGTAGTACACTT3’)
and 5’HE (5’-GGTTTTATGAATCTCCAGrrGAA-3’)
were used for cDNA synthesis
and PCR amplification.
DNA sequencing
was carried out with the modified dideoxynucleotide
chain termination
procedure
(43) using Sequenase
(USB, Cleveland,
OH).
Sequences
were analyzed
with the aid of the Sequence
Analysis
Software
Package
of the Genetics
Computer
Group of the University
of
Wisconsin
and the MacVector
Software
(IBI, New Haven, CT). The consensus
sequences
(CTAAAC)
are indicated
by asterisks.
The predicted
signal peptide and intramembrane
anchoring
sequences
are marked
by (-). Ten potential
N-linked
glycosylation
sites are underlined.
The
putative acetylesterase
active site (FGDS) is shown in boldcase.
The amino acid sequences
of two possible
internal ORFs are displayed
under
the amino acid sequence
of the large ORF. The nucleotide
sequences
of the HE gene of BRCVG95,
which differ from those of HCV-OC43,
are
displayed
above the nucleotide
sequence
of HCVOC43.
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FIG. 2. Comparison
of the amino acid sequences
of the HE proteins among human, bovine, and murine coronaviruses
and influenza
C virus.
The deduced
amino acid sequences
were aligned manually.
The conserved
cysteine
residues and the putative esterase
active sites (FGDS) are
marked by asterisks on the top. Dash (-) indicates
amino acids identical to the first sequence.
Dot (.) denotes gaps introduced
to the sequences
for maximum
alignment.
The sequence
for BCV-Mebus,
WV-Quebec,
MHV-JHM,
MHV-A59,
ICV were obtained
from Refs. 30,29,
11, and 10,
respectively.
The sequences
for BCV-L9, BCVLY138
were obtained
from recent work (44).

gested a common ancestor of this antigenic group of
coronaviruses.
The highly cell-adapted
strains BCVL9, BCV-Quebec,
and BCV-Mebus
are closely related
to the wild-types
BCV-LY138 and BRCV-G95. We excluded these strains in the final phylogenetic analysis,
because their close relationships resulted in collapsed
branches
in the phylogenetic
tree. We further attempted to analyze the relationship
among the HE
genes of selected coronaviruses
and ICV based on
these results using limited DNA sequence information,

and assuming ICV as outgroup. The highly variable regions (positions 19-l 85, 235-365,451-l
046, 12551295, 1351-1430,
and 1459-1503)
were excluded
because they were not aligned with confidence.
We
identified 125 phylogenetically
informative sites (variable sites with at least two taxa potentially sharing a
derived base) from 439 aligned base positions. The
phylogram shows an almost identical topology for the
coronaviral ingroup obtained by the previous analysis
(Fig. 3).
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BCV-LY138

I

BRCV-G95

HCWOC43

MHV-A59

MHV-JHM

FIG. 3. Phylogenetic
tree for the HE gene nucleotide
sequences
of
human, bovine, and murine coronaviruses
and ICV. The complete
HE gene sequences
of HCV-OC43.
BRCVG95,
MHV-JHM
(II),
MHVA59
(IO), and BCV-LY138
(44) and a partial HE gene sequence
of ICV (32) were used for this phylogram.
The DNA sequences were aligned based on their deduced amino acid sequence
alignment
as shown in Fig. 2. The data were analyzed
with the software package
PAUP (Phylogenetic
Analysis
Using Parsimony,
version 3.09, D. Swofford,
National
Historical
Survey,
IL) using the
MULPARS
heuristic
search option with tree bisection-reconnection
(TBR) branch-swapping.
From the alignment,
462 phylogenetically
informative
sites were identified
from 1503 aligned base positions
per taxon. Horizontal
distance
(branch-length)
is proportional
to the
number of inferred character
changes.
Vertical lines are for spacing
branches
and labels.

Since the HCV-OC43 and ICV infect similar tissues
in human subjects, the significant sequence homology
between the HE genes of the two viruses suggests that
coinfection of an ancestral coronavirus
with ICV followed by recombination
may have given rise to HCVOC43. This was also proposed by Luytjes et al. (10).
Phylogenetic analysis also suggests that the HE genes
of coronaviruses
and ICV may originate from a common ancestor. It is worth noting that the HE protein of
ICV contains receptor-binding,
acetylesterase
and fusion activities while that of coronaviruses
contains only
the receptor-binding
and acetylesterase
activities. The
fusion function of ICV is associated with the /V-terminal
hydrophobic region of the HE2 subunit of the HE protein (17- 19, 32). A similar hydrophobic domain was not
found in the coronavirus
HE protein.
The high similarity between the HE proteins of HCVOC43 and BCVs (95% identity on the average) suggests that both viruses are very closely related. This
hypothesis
is also supported by the tree branch distance in the phylogenetic analysis shown in Fig. 3. Interestingly, the HE of HCV-OC43
is more closely related to those of BRCVG95 and the wild-type, virulent
strain BCV-LY138
than to that of the cell-culture
adapted avirulent strain BCV-L9. The wild-type strain
BCV-LY138
does not replicate in numerous
bovine

cells in vitro, but it grows readily in human cells (HRT18) without
requiring prior adaptation
(27, 33, 34).
Since these polarized human cells retain many features of primary epithelial cells, infection by BCV suggests that BCV may also infect humans, and therefore,
it is a zoonotic virus (23, 35).
We previously reported a case of human diarrhea
caused by BCV-LY 138, in which the virus was identified from the infected patient (35). Recently, we found
that BRCV-G95 exhibited almost identical cytopathology in vitro to the wild-type virulent strains BCV-LY 138
(data not shown). The HCV-OC43,
BCVs, and BRCVG95 differed only in few amino acids in the HE, and
their putative acetylesterase
active sites were conserved (see Fig. 2). 0-acetylneuraminic
acid was
shown to be the major determinant
for ICV (36-38).
HCV-OC43,
BCVs, and BRCV-G95 probably recognize
this receptor on the surface of many different epithelial
cells. They may be able to replicate in epithelial cells of
both respiratory and intestinal tracts, and to cross species-barriers
causing diseases in heterologous
hosts.
However, HCV-OC43
primarily causes respiratory diseases and BCVs cause enteritis. The ability of these
viruses to replicate in different organs and to cause
different clinical symptoms
is probably due to multiple
amino acid differences
occurring within several viral
proteins. The S protein of MHV was shown to be important in tissue tropism (39).
Recently, it was reported that turkey enteric coronavirus is antigenically and genomically closely related to
BCVs (40) and similar functions were found in the HE
protein of HEV (20). Whether swines or turkeys may
also serve as reservoir (mixing-vessel)
for coronavirus
recombination
in nature, as it was proposed for influenza A viruses (41) remains to be elucidated.
It is
worth noting that ICV was also isolated from pigs (42).
It will be worthwhile
to compare the HE genes among
these coronaviruses.
Comparison
of the remaining
genes with HCV-OC43
and BCVs will provide further
insight into their evolution and host cell tropism.
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